# A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed

> **NCT03128164** · PHASE1 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 200 (actual)

## Conditions studied

- Lymphomas

## Interventions

- **DRUG:** HMPL-689

## Key facts

- **NCT ID:** NCT03128164
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-08
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03128164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03128164, "A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03128164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*